GVMXX同业对比
GVMXX 与SPDR S&P Biotech ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:XBI 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GVMXX本股 | — | — | — | — | — | — | — | — | — | — | — | — |
| MDGL | — | — | — | — | 432.1%#2 | 38.1%#5 | -31.3%#6 | -55.0%#8 | -52.5%#4 | — | — | — |
| TGTX | — | — | — | — | 87.3%#6 | 1811.1%#1 | 20.0%#3 | 74.0%#1 | 14.2%#2 | — | — | — |
| INSM | — | — | — | — | 66.7%#7 | -39.7%#10 | -205.6%#8 | -168.6%#10 | -163.0%#6 | 3#1 | — | — |
| SRRK | — | — | — | — | — | -53.7%#12 | — | -148.9%#9 | -2854.7%#7 | — | — | — |
| APGE | — | — | — | — | — | -40.5%#11 | — | — | — | — | — | — |
| PTGX | — | — | — | — | -89.4%#11 | -147.3%#14 | -343.6%#9 | -15.5%#5 | -36.7%#3 | — | 186.1%#3 | — |
| SMMT | — | — | — | — | — | -387.8%#15 | — | -171.4%#11 | — | — | -50.2%#8 | — |
| UTHR | — | — | — | — | 10.6%#9 | 11.7%#6 | 46.9%#2 | 20.9%#3 | — | — | 80.1%#5 | — |
| PRAX | — | — | — | — | -100.0%#12 | -65.6%#13 | — | -22.6%#6 | — | — | 663.7%#1 | — |
| ARWR | — | — | — | — | 23258.2%#1 | 99.7%#4 | 11.9%#5 | -0.4%#4 | — | — | 445.7%#2 | — |
| COGT | — | — | — | — | -65.0%#10 | -28.6%#7 | -4235.3%#11 | -54.1%#7 | -81.2%#5 | — | — | — |
| BBIO | — | — | — | — | 126.3%#4 | -34.9%#9 | -104.2%#7 | — | — | — | 83.9%#4 | — |
| PTCT | — | — | — | — | 114.5%#5 | 288.0%#2 | 50.1%#1 | — | — | — | 45.6%#6 | — |
| CYTK | — | — | — | — | 376.6%#3 | -33.2%#8 | -695.4%#10 | — | — | — | — | — |
| ALNY | — | — | — | — | 65.2%#8 | 212.8%#3 | 13.5%#4 | 23.2%#2 | 150.5%#1 | — | -49.6%#7 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-08。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议